Generation Bio ROA 2020-2023 | GBIO
Current and historical return on assets (ROA) values for Generation Bio (GBIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Generation Bio ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$-0.13B |
$0.38B |
-31.66% |
| 2023-09-30 |
$-0.12B |
$0.38B |
-30.89% |
| 2023-06-30 |
$-0.13B |
$0.41B |
-31.21% |
| 2023-03-31 |
$-0.13B |
$0.43B |
-32.66% |
| 2022-12-31 |
$-0.14B |
$0.38B |
-33.13% |
| 2022-09-30 |
$-0.14B |
$0.40B |
-30.98% |
| 2022-06-30 |
$-0.14B |
$0.42B |
-30.16% |
| 2022-03-31 |
$-0.13B |
$0.44B |
-27.51% |
| 2021-12-31 |
$-0.12B |
$0.48B |
-24.67% |
| 2021-09-30 |
$-0.11B |
$0.46B |
-25.64% |
| 2021-06-30 |
$-0.10B |
$0.49B |
-25.34% |
| 2021-03-31 |
$-0.09B |
$0.51B |
-24.55% |
| 2020-12-31 |
$-0.08B |
$0.29B |
-34.62% |
| 2020-06-30 |
$-0.05B |
$0.33B |
-62.84% |
| 2020-03-31 |
$-0.05B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
